United Therapeutics buy UBS Group AG
Start price
29.09.25
/
50%
€360.40
Target price
29.09.26
€494.80
Performance (%)
22.17%
Price
10:36
€440.30
Summary
This prediction is currently active. The prediction currently has a performance of 22.17%. This prediction currently runs until 29.09.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 5.068% | 5.068% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) had its "buy" rating reaffirmed by analysts at UBS Group AG. They now have a $580.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€393.20
06.11.25
06.11.25
€521.34
06.11.26
06.11.26
11.98%
10:36
10:36
United Therapeutics
Start price
Target price
Perf. (%)
€337.60
04.09.25
04.09.25
€480.20
04.09.26
04.09.26
30.42%
10:36
10:36
United Therapeutics
Start price
Target price
Perf. (%)
€258.80
13.08.25
13.08.25
€355.41
13.08.26
13.08.26
70.13%
10:36
10:36
United Therapeutics
Start price
Target price
Perf. (%)
€244.10
30.06.25
30.06.25
€328.48
30.06.26
30.06.26
80.38%
10:36
10:36
United Therapeutics
Start price
Target price
Perf. (%)
€355.30
08.01.25
08.01.25
€460.94
08.01.26
08.01.26
23.92%
10:36
10:36
United Therapeutics
Start price
Target price
Perf. (%)
€292.80
08.07.24
08.07.24
€341.51
08.07.25
08.07.25
-14.82%
09.07.25
09.07.25